Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

APYX Apyx Medical Inc

Market Closed 03-21 16:00:00 EDT

1.26

+0.10

+8.62%

盘后1.26

+0.000.00%

16:55 EDT

High1.34	Low1.19	Vol75.62K
Open1.22	D1 Closing1.16	Amplitude12.94%
Mkt Cap47.62M	Tradable Cap32.54M	Total Shares37.79M
T/O94.81K	T/O Rate0.29%	Tradable Shares25.83M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"APYX","market":"US","secType":"STK","nameCN":"Apyx Medical Inc","latestPrice":1.26,"timestamp":1742587200000,"preClose":1.16,"halted":0,"volume":75621,"hourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"16:55 EDT","volume":5,"amount":6.3,"timestamp":1742590528692},"delay":0,"floatShares":25829135,"shares":37793886,"eps":-0.660148,"marketStatus":"Market Closed","change":0.1,"latestTime":"03-21 16:00:00 EDT","open":1.22,"high":1.3351,"low":1.185,"amount":94813.2014466,"amplitude":0.129397,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.660148,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1742803200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.16,"postHourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"16:55 EDT","volume":5,"amount":6.3,"timestamp":1742590528692},"volumeRatio":1.6592649529851253,"impliedVol":0.8989,"impliedVolPercentile":0.992},"requestUrl":"/m/hq/s/APYX","defaultTab":"news","newsList":[{"id":"2519088878","title":"Apyx Medical Full Year 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2519088878","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519088878?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 19:14","pubTimestamp":1741950857,"startTime":"0","endTime":"0","summary":"NasdaqGS:APYX Earnings and Revenue Growth March 14th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 1.7%. Earnings per share  also surpassed analyst estimates by 7.5%.Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Medical Equipment industry in the US.The company's shares are down 12% from a week ago.It is worth noting though that we have found 2 warning signs for Apyx Medical that you need to take into consideration.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apyx-medical-full-2024-earnings-111417120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APYX"],"gpt_icon":0},{"id":"2519406768","title":"Apyx Medical Corp (APYX) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2519406768","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519406768?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 15:03","pubTimestamp":1741935832,"startTime":"0","endTime":"0","summary":"Total Revenue: $14.2 million for Q4 2024, a decrease of 3% from $14.7 million in Q4 2023.Advanced Energy Segment Revenue: $12.1 million, flat year over year, but a 30% increase from Q3 2024.OEM Segment Sales: Decreased 16% or approximately $0.3 million compared to Q4 2023.Domestic Revenue: Increased 1% year over year to $10.6 million.International Revenue: Decreased 8% year over year to $3.7 million.Gross Profit: $9 million, up from $8.9 million in Q4 2023.Gross Profit Margin: 63.0% compared to 60.9% in Q4 2023.Operating Expenses: Decreased to $12 million from $14.7 million in Q4 2023.Net Loss: $4.6 million or $0.12 per share, compared to $9.6 million or $0.28 per share in Q4 2023.Adjusted EBITDA Loss: Decreased 53% to $2.2 million from $4.7 million in Q4 2023.Cash Used in Operating Activities: $2.9 million, up from $2.2 million in Q4 2023.Apyx Medical Corp  reported stronger-than-expected sales in its advanced energy segment, with a 30% growth compared to the sequential third quarter ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apyx-medical-corp-apyx-q4-070352615.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APYX"],"gpt_icon":0},{"id":"2519814675","title":"Q4 2024 Apyx Medical Corp Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2519814675","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519814675?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 11:40","pubTimestamp":1741923613,"startTime":"0","endTime":"0","summary":"Charles Goodwin; President and Chief Executive Officer; Apyx Medical Corp. Greetings. Welcome to the Apyx Medical fourth quarter and full year 2024 conference call.  As a reminder, this conference is being recorded. It's now my pleasure to introduce Jeremy Feffer with Investor Relations. Jeremy, you may begin.Thank you, Jeremy, and thank you all for joining us today. Per our usual format on these quarterly calls, I will be providing a review of our performance in the fourth quarter and full year 2024, and then I will turn the call over to Matt for a review of our fourth quarter and full year 2024 financial results, as well as our full year 2025 guidance. We will then open the call for questions. Let me start with a review of our fourth quarter performance. We reported total revenue of $14.2 million for the quarter, a slight decrease of 3% compared to $14.7 million for the same period last year. Looking at this by segment, sales of our advanced energy products exceeded our expectations ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-apyx-medical-corp-034013235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APYX"],"gpt_icon":0},{"id":"2519612857","title":"Apyx Medical participates in a conference call with Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2519612857","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519612857?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 00:45","pubTimestamp":1741884308,"startTime":"0","endTime":"0","summary":"President & CEO Goodwin and Dr. Paul Ruff, Apyx Medical (APYX) Advisory Board hold a conference call to introduce the Ayon Body Contouring System t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apyx-medical-participates-in-a-conference-call-with-craig-hallum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apyx-medical-participates-in-a-conference-call-with-craig-hallum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","APYX"],"gpt_icon":0},{"id":"2519340718","title":"Apyx Medical Corp reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2519340718","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519340718?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 21:32","pubTimestamp":1741872740,"startTime":"0","endTime":"0","summary":"Apyx Medical Corp reports results for the quarter ended December 31 - Earnings SummaryApyx Medical Corp APYX.OQ reported a quarterly adjusted loss of 12 cents per share for the quarter ended December ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL8N3PW190:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX"],"gpt_icon":0},{"id":"2519880250","title":"Apyx: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2519880250","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519880250?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:13","pubTimestamp":1741864402,"startTime":"0","endTime":"0","summary":"CLEARWATER, Fla.  — CLEARWATER, Fla.  — Apyx Medical Corporation  on Thursday reported a loss of $4.6 million in its fourth quarter.On a per-share basis, the Clearwater, Florida-based company said it had a loss of 12 cents.The medical device maker posted revenue of $14.2 million in the period.For the year, the company reported that its loss widened to $23.5 million, or 66 cents per share. Revenue was reported as $48.1 million.The company's shares closed at $1.07. A year ago, they were trading at $1.72.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apyx-q4-earnings-snapshot-111322773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APYX"],"gpt_icon":0},{"id":"2519887496","title":"Apyx Medical Q4 2024 GAAP EPS $(0.12) Beats $(0.15) Estimate, Sales $14.22M Beat $13.39M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887496","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887496?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:02","pubTimestamp":1741863776,"startTime":"0","endTime":"0","summary":"Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 57.14 percent increase over losses of $(0.28) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44298421/apyx-medical-q4-2024-gaap-eps-0-12-beats-0-15-estimate-sales-14-22m-beat-13-39m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Apyx Medical Q4 2024 GAAP EPS $(0.12) Beats $(0.15) Estimate, Sales $14.22M Beat $13.39M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX"],"gpt_icon":0},{"id":"2519887741","title":"Apyx Medical Corp Outlook FY Total Revenue $47.6 Mln - $49.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887741?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:00","pubTimestamp":1741863605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLXCD5F35:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"gpt_icon":0},{"id":"2519887620","title":"Apyx Medical Corporation Q4 Adjusted Ebitda USD -2.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887620?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:00","pubTimestamp":1741863605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLXCD5F35:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"gpt_icon":0},{"id":"2519160887","title":"Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2519160887","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519160887?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:00","pubTimestamp":1741863600,"startTime":"0","endTime":"0","summary":"The number of single-use handpiece units shipped in Q4 2024 exceeded expectations, increasing 5% overall and 20% in the U.S. compared to the same period last year. Submitted a 510 premarket notification to the U.S. FDA for the AYON Body Contouring System ahead of schedule and preparing for a planned launch in the back half of 2025, pending clearance. CLEARWATER, Fla., March 13, 2025  -- Apyx Medical Corporation  , the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion, today reported the financial results for its fourth quarter and year ended December 31, 2024.Reported total revenue of $14.2 million in the fourth quarter of 2024, driven by positive momentum in U.S. capital equipment and single-use handpiece sales growth. Adjusted EBITDA loss decreased by $2.5 million, or 53%, to $2.2 million for the fourth quarter of 2024, compared with $4.7 million for the fourth quarter of 2023.Submitted a 510 premarket notification to the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apyx-medical-corporation-reports-fourth-110000796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","APYX"],"gpt_icon":0},{"id":"2518471593","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471593?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 18:00","pubTimestamp":1741687200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Allbirds Inc. Class A                           4Q       4:05 PM. ·Dick's Sporting Gds                              4Q      3.52   7:00 AM. ·E. W. Scripps Co                                 4Q      1.01       AMC. ·European Wax Ctr                                4Q       .06   6:00 AM. ·First Watch Rest                                4Q       .01   7:00 AM. ·Kanzhun Ltd. Sp ADR                               4Q       .22       BMO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRUG","SPRB","BIRD","SID","BTMD","SKIN","AFCG","DKS","ATLC","SKYX","SSP","ACHV","MNTK","MGTX","ARCO","ONDS","QRHC","NOA","RMBL","EBR","HLLY","LEGN","ABM","WSM","KRMD","TH","BZ","PHLT","FTCI","BBCP","EXK","LRMR","AKBA","APYX","KSS","EWCZ","BLDE","KFY","S","VTS","WEST","KALV","BW","AGEN","ASRT","SMSI","ZYXI","BWAY","UNFI"],"gpt_icon":1},{"id":"2514389414","title":"Apyx Medical Insiders Placed Bullish Bets Worth US$2.19m","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389414","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389414?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 22:18","pubTimestamp":1740665916,"startTime":"0","endTime":"0","summary":"Multiple insiders secured a larger position in Apyx Medical Corporation  shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the company's prospects.Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.Apyx Medical Insider Transactions Over The Last Year. In the last twelve months, the biggest single purchase by an insider was when Executive Chairman Stavros Vizirgianakis bought US$2.2m worth of shares at a price of US$1.25 per share. We do like to see buying, but this purchase was made at well below the current price of US$1.43. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apyx-medical-insiders-placed-bullish-141836938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APYX","BK4082"],"gpt_icon":0},{"id":"2514480467","title":"Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514480467","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514480467?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"CLEARWATER, Fla., Feb.  27, 2025  (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency techno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033787/0/en/Apyx-Medical-Corporation-to-Release-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-on-March-13-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"gpt_icon":0},{"id":"2508468341","title":"Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH) and Apyx Medical (APYX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468341","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508468341?lang=en_us&edition=full_marsco","pubTime":"2025-02-04 23:01","pubTimestamp":1738681274,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx Med...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-and-apyx-medical-apyx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-and-apyx-medical-apyx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0162691827.USD","LU0310800965.SGD","HCSG","LU0128525689.USD","APYX","BK4588","LU1267930813.SGD","LU0154236417.USD","BK4585","BK4137","LU0792757196.USD","LU1571399168.USD","BK4082","LU0006061336.USD","LU0310799852.SGD","LU1267930490.SGD","LU0211327993.USD","LU1880398554.USD","BK4175","LU0052756011.USD","LU1267930227.SGD","LU1880398471.USD","LU0889566641.SGD","LU0211328371.USD","CAH","LU0072461881.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2503575301","title":"Apyx Medical (APYX) Gets a Buy from Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2503575301","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503575301?lang=en_us&edition=full_marsco","pubTime":"2025-01-14 21:46","pubTimestamp":1736862372,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Apyx Medical (APYX – Research Report) today. The company’s shares closed yesterday at $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/apyx-medical-apyx-gets-a-buy-from-craig-hallum-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/apyx-medical-apyx-gets-a-buy-from-craig-hallum-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","APYX"],"gpt_icon":0},{"id":"2503938309","title":"Apyx Medical Corp  Q4 REV View $13.0 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2503938309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503938309?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 21:02","pubTimestamp":1736773356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90QA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"gpt_icon":0},{"id":"2503647309","title":"Apyx Medical Corp - Q4 Total Revenue Expected to Be $14.1-$14.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503647309?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 21:02","pubTimestamp":1736773356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"gpt_icon":0},{"id":"2503309984","title":"Apyx Medical Corp  FY2024 REV View $46.9 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309984?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 21:02","pubTimestamp":1736773356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90QA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APYX","BK4082"],"gpt_icon":0},{"id":"2503030964","title":"Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2503030964","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503030964?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"Advanced Energy revenue increase by more than 25% quarter-over-quarter in Q4 2024. CLEARWATER, Fla, Jan. 13, 2025  -- Apyx Medical Corporation  , the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2024.Total revenue expected to be in a range of approximately $14.1 to $14.3 million, representing a decrease of 4% to 3% year-over-year.Advanced Energy revenue expected to be in a range of approximately $12.0 to $12.2 million, which is relatively flat year-over-year.OEM revenue expected to be approximately $2.1 million, representing a decrease of 17% year-over-year.Advanced Energy revenue expected to be in a range of approximately $38.5 to $38.7 million, representing a decrease of 11% year-over-year.Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apyx-medical-corporation-reports-preliminary-130000155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["APYX"],"gpt_icon":0},{"id":"2501231186","title":"BRIEF-Apyx Medical Submits 510(K) Premarket Notification To The U.S. FDA For The Ayon Body Contouring System","url":"https://stock-news.laohu8.com/highlight/detail?id=2501231186","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501231186?lang=en_us&edition=full_marsco","pubTime":"2025-01-06 21:23","pubTimestamp":1736169797,"startTime":"0","endTime":"0","summary":"BRIEF-Apyx Medical Submits 510 Premarket Notification To The U.S. FDA For The Ayon Body Contouring SystemJan 6  - Apyx Medical Corp APYX.O:APYX MEDICAL CORPORATION SUBMITS 510 PREMARKET NOTIFICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR THE AYON BODY CONTOURING SYSTEMAPYX MEDICAL CORP - ADDITIONAL 510 SUBMISSION FOR AYON PLANNED LATER THIS YEARSource text: nGNXczY0pFurther company coverage: APYX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA5WZFJY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apyxmedical.com","stockEarnings":[{"period":"1week","weight":0.26},{"period":"1month","weight":-0.1515},{"period":"3month","weight":-0.1975},{"period":"6month","weight":-0.0308},{"period":"1year","weight":-0.0455},{"period":"ytd","weight":-0.2025}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0799},{"period":"3month","weight":-0.046},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.08},{"period":"ytd","weight":-0.0377}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.049685},{"month":2,"riseRate":0.451613,"avgChangeRate":0.033972},{"month":3,"riseRate":0.225806,"avgChangeRate":-0.096801},{"month":4,"riseRate":0.7,"avgChangeRate":0.047536},{"month":5,"riseRate":0.483871,"avgChangeRate":0.053516},{"month":6,"riseRate":0.451613,"avgChangeRate":0.022431},{"month":7,"riseRate":0.645161,"avgChangeRate":0.036091},{"month":8,"riseRate":0.483871,"avgChangeRate":0.027773},{"month":9,"riseRate":0.419355,"avgChangeRate":0.018572},{"month":10,"riseRate":0.419355,"avgChangeRate":-0.000783},{"month":11,"riseRate":0.451613,"avgChangeRate":0.035247},{"month":12,"riseRate":0.4,"avgChangeRate":-0.00273}],"exchange":"NASDAQ","name":"Apyx Medical Inc","nameEN":"Apyx Medical Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Apyx Medical Inc(APYX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Apyx Medical Inc,APYX,Apyx Medical Inc股票,Apyx Medical Inc股票老虎,Apyx Medical Inc股票老虎国际,Apyx Medical Inc行情,Apyx Medical Inc股票行情,Apyx Medical Inc股价,Apyx Medical Inc股市,Apyx Medical Inc股票价格,Apyx Medical Inc股票交易,Apyx Medical Inc股票购买,Apyx Medical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Apyx Medical Inc(APYX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction